Apple is facing another significant financial penalty after being ordered to pay an additional $184 million to medical technology firm Masimo. The latest development stems from an ongoing legal dispute over patent infringement related to Apple Watch technology.
The long-running battle between the two companies has focused on advanced health-monitoring features integrated into Apple's popular smartwatch lineup. Masimo has claimed that Apple infringed upon its proprietary patents to develop specialized sensor capabilities, including blood oxygen monitoring.
This decision marks another setback for Apple in its efforts to defend its wearable health features, which have previously triggered regulatory scrutiny and temporary sales disruptions for select watch models.
For full details and further legal context regarding the ruling, be sure to check the original reporting on 9to5Mac.
